HU164525B - - Google Patents
Info
- Publication number
- HU164525B HU164525B HUTA1163A HUTA001163A HU164525B HU 164525 B HU164525 B HU 164525B HU TA1163 A HUTA1163 A HU TA1163A HU TA001163 A HUTA001163 A HU TA001163A HU 164525 B HU164525 B HU 164525B
- Authority
- HU
- Hungary
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP45124064A JPS4935635B1 (en:Method) | 1970-12-28 | 1970-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU164525B true HU164525B (en:Method) | 1974-02-28 |
Family
ID=14876047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUTA1163A HU164525B (en:Method) | 1970-12-28 | 1971-12-23 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3819613A (en:Method) |
| JP (1) | JPS4935635B1 (en:Method) |
| BE (1) | BE777223A (en:Method) |
| CA (1) | CA952102A (en:Method) |
| DE (1) | DE2163790A1 (en:Method) |
| FR (1) | FR2120040A1 (en:Method) |
| HU (1) | HU164525B (en:Method) |
| NL (1) | NL7117787A (en:Method) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157443A (en) * | 1976-11-11 | 1979-06-05 | Ciba-Geigy Corporation | V-Triazolyl-[4,5-d]-pyrimidines |
| US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
| US5155098A (en) * | 1989-06-09 | 1992-10-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them |
| US5278150A (en) * | 1992-04-24 | 1994-01-11 | Whitby Research, Inc. | 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions |
| DK62592D0 (en:Method) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| EP0704215A3 (en) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibitor of vascular permeability enhancer |
| US5972903A (en) * | 1997-10-07 | 1999-10-26 | Regents Of The University Of California Corporation | Method for promoting angiogenesis using heparin and adenosine |
| EP1021195A1 (en) | 1997-10-07 | 2000-07-26 | The Regents Of The University Of California | Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| US7423144B2 (en) * | 2004-05-26 | 2008-09-09 | Inotek Pharmaceuticals Corporation | Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof |
| BRPI0619261A2 (pt) * | 2005-11-30 | 2011-09-27 | Inotek Pharmaceuticals Corp | derivados de purina e métodos de uso desses |
| LT2523669T (lt) | 2010-01-11 | 2017-04-25 | Inotek Pharmaceuticals Corporation | Akispūdžio mažinimo būdas, derinys ir rinkinys |
| AU2011230580A1 (en) | 2010-03-26 | 2012-10-11 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof |
| PL2807178T3 (pl) | 2012-01-26 | 2017-12-29 | Inotek Pharmaceuticals Corporation | Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania |
| WO2014152723A1 (en) | 2013-03-15 | 2014-09-25 | Inotek Pharmaceuticals Corporation | Ophthalmic formulations |
| WO2020253870A1 (zh) * | 2019-06-21 | 2020-12-24 | 中国人民解放军军事科学院军事医学研究院 | 具有a2a腺苷受体激动剂活性的6-肼基腺苷类化合物 |
-
1970
- 1970-12-28 JP JP45124064A patent/JPS4935635B1/ja active Pending
-
1971
- 1971-12-22 DE DE19712163790 patent/DE2163790A1/de active Pending
- 1971-12-22 US US00211107A patent/US3819613A/en not_active Expired - Lifetime
- 1971-12-23 CA CA130,987A patent/CA952102A/en not_active Expired
- 1971-12-23 NL NL7117787A patent/NL7117787A/xx unknown
- 1971-12-23 HU HUTA1163A patent/HU164525B/hu unknown
- 1971-12-23 BE BE777223A patent/BE777223A/xx unknown
- 1971-12-27 FR FR7146835A patent/FR2120040A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE2163790A1 (de) | 1972-07-20 |
| JPS4935635B1 (en:Method) | 1974-09-25 |
| FR2120040A1 (en:Method) | 1972-08-11 |
| CA952102A (en) | 1974-07-30 |
| NL7117787A (en:Method) | 1972-06-30 |
| US3819613A (en) | 1974-06-25 |
| BE777223A (fr) | 1972-06-23 |